Lawmakers send mixed messages on controlled substances
This article was originally published in Scrip
Executive Summary
Lawmakers sent mixed messages during a 7 April hearing of the House Energy & Commerce Subcommittee on Health, in which the Drug Enforcement Administration (DEA) and the FDA were told to speed up their processes for scheduling controlled substances to get those products on the US marker quicker, while also upping their game on protecting the public from the epidemic of prescription drug abuse.